Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial

Published:2020-05 Issue:5 Volume:42 Page:848-859
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Rezvani Hamid,Mortazavizadeh Seyed Mohammadreza,Allahyari Abolghasem,Nekuee Amirabbas,Najafi Safa Najjar,Vahidfar Mohammadreza,Ghadyani Mojtaba^ORCID,Khosravi Adnan,Qarib Siroos,Sadeghi Alireza,Esfandbod Mohsen,Rajaeinejad Mohsen,Rezvani Alireza,Hajiqolami Ali,Payandeh Mehrdad,Shazad Babak,Anjidani Nassim,Meskinimood Shahab^ORCID,Alikhasi Afsaneh,Karbalaeian Moein,Salari Sina

Funder

AryoGen Pharmed Company

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. Skin lightening preparations and the hydroquinone controversy;Draelos;Dermatol Ther,2007

2. Colon and rectum cancer. Patterns of spread and implications for workup;Niederhuber;Cancer,1993

3. Patterns of metastasis in colon and rectal cancer;Riihimäki;Sci Rep,2016

4. Andrews' Diseases of the Skin;James,2011

5. Surgical management of colorectal lung metastasis;Villeneuve;Clin Colon Rectal Surg,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of bevacizumab biosimilar on wound healing complications in patients with colorectal cancer undergoing endoscopic mucosal resection: A systematic review and meta‐analysis in anorectal medicine;International Wound Journal;2024-01

2. Clinical Benefit, Price, and Uptake for Cancer Biosimilars vs Reference Drugs in China;JAMA Network Open;2023-10-12

3. Adverse event reporting of marketed biosimilar and biological monoclonal antibody cancer treatments in the United States;Expert Opinion on Biological Therapy;2023-03-09

4. Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis;BioDrugs;2023-02-02

5. Efficacy and Safety of Bevacizumab Biosimilars Compared With Reference Biologics in Advanced Non-small Cell Lung Cancer or Metastatic Colorectal Cancer Patients: A Network Meta-Analysis;Frontiers in Pharmacology;2022-07-05